Show results for
Refine by
Metabolic Bone Disease Services Available In Ireland
11 services found
by:Protheragen-ING based inNEW YORK (USA)
Hypoglycemic APIs are a class of compounds designed to control and treat diabetes, a chronic metabolic disease characterized by hyperglycemia. Protheragen-ING provides a full range of anti-diabetic APIs, covering biguanides, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibition agents and glucagon-like peptide 1 (GLP-1) ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Over the past two decades, extensive collections of zebrafish lines carrying mutations in genes involved in early embryonic development have been generated—some of these mutations in genes important for eye formation and associated with eye malformations in humans. Besides, many transgenic lines have been generated at Creative Biogene to enable the close monitoring of organogenesis and the ...
Manufactured by:RareStone Group based inShanghai, CHINA
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
Manufactured by:RareStone Group based inShanghai, CHINA
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological diseases. ...
by:Curome BioSciences based inheongju-si, SOUTH KOREA
Mitochondria are an essential cellular organelle that is responsible for the generation of energy (known as the ‘powerhouse of the cell’). Mitochondrial dysfunction is related with numerous diseases. Curome Biosciences is researching a treatment to improve mitochondrial dysfunction by inducing mitochondrial activation through the increase in NAD+, an essential cofactor of the redox ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Biological drugs are macromolecules manufactured in, extracted from or semi synthesized by modern biotechnological methods within a living organism and can be composed of sugars, proteins, nucleic acids or complex combinations of these substances, or may be living cells or tissues. They are widely used in the diagnosis, treatment or prevention of diseases such as cancer, cardiovascular diseases, ...
by:PharmaBiome AG based inSchlieren, SWITZERLAND
The human microbiome fulfills a variety of functions. Each function is ascribed a set of bacteria, and these all have various functions under different circumstances. A bacterial consortium needs to be versatile, balanced and cover all the essential ...
by:Azafaros based inNaarden, NETHERLANDS
Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. These disorders are individually rare but collectively affect 1 in 5,000 live births. They typically present in infancy and childhood, although adult-onset forms also occur. Most LSDs have a progressive neurodegenerative ...
by:SGS M-SCAN Ltd based inWokingham, UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. We have also invested in the field of multiplexing, using ...
by:Activation Laboratories Ltd. based inAncaster, ONTARIO (CANADA)
ActLabs Biotech scientists can assist with innovative biomarker assay development and validation. To compliment our range of immunoassays, we also offer LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers. In addition, we have invested in the field of multiplexing, using a bead-based suspension and electro-chemiluminescence-based platform ( Luminex Biorad ...
by:Teijin Limited based inTokyo, JAPAN
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of pharmaceuticals and home ...